ÇѸ²´ëÇб³¼º½Éº´¿ø

¹®¿ë¼® ±³¼ö

1577-5587
  • Áø·á°ú ¾È°ú

Àü¹®Áø·áºÐ¾ß

Ȳ¹Ýº¯¼º, ´ç´¢¸Á¸·, ¸Á¸·¹Ú¸®, ¿­°ø, ±âŸ ¸Á¸·/Æ÷µµ¸· Áúȯ, ½Å»ý¾Æ ¸Á¸·º´Áõ

ÀüÈ­ ¿¹¾à 1577-5587
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-05-20 ~ 2024-05-25)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·áÁÖ»çŬ¸®´Ð¿Ü·¡Áø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

2002.03 ~ 2010.02¼­¿ï´ëÇб³ Àü±â°øÇÐ Á¹¾÷

2010.03 ~ 2014.02¼­¿ï´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ÀÇÇÐ Á¹¾÷

°æ·Â

°æ·Â

~ 2015¼­¿ï´ëÇб³º´¿ø ÀÎÅÏ

2015 ~ 2019¼­¿ï´ëÇб³º´¿ø ¾È°ú Àü°ø

2019 ~ 2021ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾È°ú ÀÓ»ó°­»ç

2021 ~ ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¾È°ú ÀÓ»ó°­»ç

2022 ~ ÇѸ²´ëÇб³°­³²¼º½Éº´¿ø ¾È°ú ÀÓ»óÁ¶±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇѾȰúÇÐȸ

Association for Research in Vision and Ophthalmology

³í¹®

¡Ý ±¹³»ÇÐȸÁö ¹ßÇ¥³í¹®
1. Mun YS, Ha A, Jeoung JW, Park KH, Kim YK. Comparison of Mean Optic Disc Cup Surface Depth between Primary Open-angle Glaucoma and Glaucoma-like Disc. J Korean Ophthalmol Soc 2018;59(6):556-60.
(Å« À¯µÎÇÔ¸ôºñ¸¦ °®´Â ³ì³»Àå¸ð¾ç½Ã½Å°æÀ¯µÎ¿Í¿ø¹ß°³¹æ°¢³ì³»Àå¾È ½Ã½Å°æÀ¯µÎÇÔ¸ô ±íÀÌ ºñ±³)

2. Mun YS, Yang HK, Hwang JM. Treatment of Bilateral Tonic Pupil Associated with Syphilis. J Korean Ophthalmol Soc 2018;59(7):697-701.
(¸Åµ¶¿¡ µ¿¹ÝµÈ ¾ç¾È ±äÀ嵿°øÀÇ Ä¡·á)

3. Mun YS, Kim N, Choung HK, Khwarg SI. Eyelid Schwannoma Mimicking Eyelid Amelanotic Nevus. Korean J Ophthalmol 2019;33(5):478-80.
(¹«»ö¼Ò¼º ´«²¨Ç® ¸ð¹ÝÀ» ¸ð¹æÇÑ ´«²¨Ç® ½Å°æÁýÁ¾)

¡Ý ±¹Á¦ÇÐȸÁö ¹ßÇ¥³í¹®
1. Mun Y, Kwon JW, Oh JY. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease. BMC Ophthalmol 2018;18(1):237.
(ªÀº ´«¹°¸·ÆÄ°ú½Ã°£À» º¸ÀÌ´Â °Ç¼º¾È ȯÀÚ¿¡¼­ 3% µðÄí¾ÆÆ÷Á¹ Á¡¾È¾×ÀÇ Ä¡·áÈ¿°ú)

2. Mun Y, Kim MK, Oh JY. Ten-year analysis of microbiological profile and antibiotic sensitivity for bacterial keratitis in Korea. PLoS One 2019;14(3):e0213103.
(10³â°£ Çѱ¹ÀÇ ¼¼±º °¢¸·¿°ÀÇ ¹Ì»ý¹°ÇÐÀû ÇÁ·ÎÆÄÀÏ°ú Ç×»ýÁ¦ °¨¼ö¼º¿¡ ´ëÇÑ ºÐ¼®)

3. Joo K, Mun YS, Park SJ, Park KH, Woo SJ. Ten-year Progression from Intermediate to Exudative Age-related Macular Degeneration and Risk Factors-Bundang AMD Cohort Study Report 1. Am J Ophthalmol 2020.
(10³â°£ Áߵ °Ç¼º ³ªÀÌ°ü·ÃȲ¹Ýº¯¼º¿¡¼­ ½À¼º ³ªÀÌ°ü·ÃȲ¹Ýº¯¼ºÀ¸·ÎÀÇ ÁøÇà°ú ±×¿¡ ´ëÇÑ À§ÇèÀÎÀÚ ºÐ¼® – ºÐ´ç¼­¿ï´ëÇб³º´¿ø ³ªÀÌ°ü·ÃȲ¹Ýº¯¼º ÄÚȣƮ)

4. Mun Y, Kim J, Noh KJ, Lee S, Kim S, Yi S, Park KH, Yoo S, Chang DJ, Park SJ. An innovative strategy for standardized, structured, and interoperable results in ophthalmic examinations. BMC Med Inform Decis Mak 2021;21(1):9.
(¾È°ú °Ë»ç °á°úÀÇ Ç¥ÁØÈ­, ±¸Á¶È­, »óÈ£¿î¿ë¼º È®´ë¸¦ À§ÇÑ Çõ½ÅÀû Àü·«)

5. Yang L, Joo K, Tsunoda K, Kondo M, Fujinami-Yokokawa Y, Arno G, Pontikos N, Liu X, Nakamura N, Kurihara T, Tsubota K, Iwata T, Li H, Zou X, Wu S, Sun Z, Ahn SJ, Kim MS, Mun YS, Park KH, Robson AG, Miyake Y, Woo SJ, Sui R, Fujinami K. Spatial Functional Characteristics of East Asian Patients With Occult Macular Dystrophy (Miyake Disease); EAOMD Report No. 2. Am J Ophthalmol 2021;221:169-80.
(µ¿¾Æ½Ã¾ÆÀÎÀÇ RP1L1 °ü·Ã Àẹ Ȳ¹ÝÀÌ»óÁõ (¹Ì¾ßÄɺ´)ÀÇ Ç¥ÇöÇüÀû, ±â´ÉÀû Ư¼º)

°Ç°­Á¤º¸ µ¿¿µ»ó